ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
61 hedge funds and large institutions have $12.5M invested in Zynerba Pharmaceuticals, Inc in 2019 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
44% less call options, than puts
Call options by funds: $1.16M | Put options by funds: $2.09M
Holders
61
Holding in Top 10
–
Calls
$1.16M
Puts
$2.09M
Top Buyers
| 1 | +$1.49M | |
| 2 | +$504K | |
| 3 | +$486K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$382K |
| 5 |
PP
PDT Partners
New York
|
+$186K |
Top Sellers
| 1 | -$830K | |
| 2 | -$607K | |
| 3 | -$547K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$427K |
| 5 |
SIM
Spark Investment Management
New York
|
-$409K |